Ketamine and Dexmedetomidine for Delirium in Joint Arthroplasty
Key facts
- Who runs it
- Istinye University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 80 people, planned
- Started
- 5 May 2026
- Planned end
- 15 Jul 2026
- Type of study
- Interventional, 4 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Ketamine
- Record updated
- 9 May 2025
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Scheduled for elective total joint arthroplasty (hip or knee)
- ASA physical status I-III
- Age between 18 and 100 years
- Ability to provide informed consent and comply with cognitive assessments
Who cannot take part
- Pre-existing cognitive dysfunction or diagnosed neurodegenerative disease
- Hearing or language impairment interfering with MMSE/CAM evaluation
- Known allergy to ketamine or dexmedetomidine
- Significant cardiac arrhythmia (e.g., supraventricular tachycardia, 2nd or 3rd degree AV block)
- Renal insufficiency (GFR <30 mL/min/1.73 m²)
- Severe hepatic dysfunction
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, randomized, double-blind, placebo-controlled clinical trial aims to evaluate the effects of intraoperative ketamine and dexmedetomidine on the incidence of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) in patients undergoing total joint arthroplasty. Given the high incidence of neurocognitive complications in elderly patients following major orthopedic surgeries, neuroprotective strategies during anesthesia are of growing interest. Both ketamine and dexmedetomidine have shown potential in reducing neuroinflammation and improving postoperative cognitive outcomes in previous studies.
Read full original descriptionShow less
Eighty adult patients (ASA I-III, aged 18-100) scheduled for elective total hip or knee arthroplasty under spinal anesthesia will be randomized into four groups: control (saline infusion), ketamine infusion, dexmedetomidine infusion, and combined ketamine + dexmedetomidine. Cognitive assessments will be performed preoperatively and on postoperative days 2 and 15 using the Mini Mental State Examination (MMSE). Delirium assessments will be conducted using the Confusion Assessment Method (CAM) postoperatively on days 1, 3, and 15.
Secondary outcomes include perioperative levels of cortisol, CRP, and fibrinogen, as well as postoperative pain scores (VAS) and analgesic consumption. The results are expected to clarify whether intraoperative administration of ketamine or dexmedetomidine can reduce the incidence of POD/POCD and improve postoperative recovery.
The 4 groups in the trial
- Saline InfusionPlacebo, for comparison
Participants receive 0.9% saline at 30 mL/hour during surgery.
Treatment: Ketamine
- Ketamine InfusionTreatment being tested
Participants receive ketamine at 0.1 mg/kg/hour as intraoperative infusion
Treatment: Ketamine
- Dexmedetomidine InfusionTreatment being tested
Participants receive dexmedetomidine at 0.5 mcg/kg/hour as intraoperative infusion
Treatment: Ketamine
- Ketamine + DexmedetomidineTreatment being tested
Participants receive a combination of ketamine (0.3 mg/kg/hour) and dexmedetomidine (0.5 mcg/kg/hour) as intraoperative infusion.
Treatment: Ketamine
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Intraoperative Ketamine and Dexmedetomidine Use on Postoperative Delirium and Cognitive Dysfunction in Patients Undergoing Total Joint Arthroplasty
- Fit questions
- Built from NCT06963294, who can take part
- Record updated
- 9 May 2025